12 Dec 2018, 12 CET
This webinar of the VPHi Keynote Webinar Series took place on 12 Dec 2018 at 12 CET featuring Luca Emili from InSilicoTrials Technologies.
The webinar presents how modeling & simulation combined with a changing regulation can accelerate the development and approval of new drugs and medical devices. New regulations in Europe, guidance, and initiatives from the US combined with the availability of validated models are defining a new way to innovate in the life sciences industry. Dr Emili shows how a combination of regulations, technologies, and science is necessary to proceed in this pathway.
The VPHi keynote webinar series is a quarterly event organized by the VPHi Student Committee that provides a forum for access to senior community members and their expert competence for chiefly young scientists, but also to the VPH community as a whole.
The webinar is organised and moderated by Alessia Pin from University of Trieste, IRCCS Burlo Garofolo Trieste, active member of the VPHi Student Committee.
Short Bio
Luca Emili is founder and CEO of Insilicotrials Technologies. With a strong passion for technology, he is focused on the development of the company for the definition of partnership with Research centers, hospitals and pharma and medical devices companies and the development of new innovative technology and services. Prior to founding Insilicotrials Technologies he worked in M&A and acted as an investor in some SME companies. From 2001 to 2010 was CEO of Emaze, an IT Security Company backed by Alice Venture, Venture Capital with funds from Mediobanca, Generali, Pirelli, Bracco, Dompè and other Italian firms. As a journalist, he published more than 40 articles on IT security Journals. Before Emaze he was a professor of IT at the MIB School of Management of Trieste, as well as an entrepreneur in the internet services business. He has a degree in Economy and Business from the University of Trieste.
